Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Der Unfallchirurg
|
July 12, 2018
[Corrective osteotomy of the hand]
Frank Unglaub, Martin F Langer, Julia M Unglaub, et al.
International Orthopaedics
|
September 1, 2020
Long-term functional outcome after dorsal capsular imbrication for post-traumatic dorsal instability of the distal radioulnar joint
Julia M Unglaub, Thomas Heyse, Thomas Bruckner, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
July 29, 2021
Long-term results of more than 13 years after arthroscopic repair of triangular fibrocartilage complex (TFCC) Palmer 1B tears: a comparison with short- and mid-term results
Julia M Unglaub, Thomas Bruckner, Thomas J Heyse, et al.
Journal of Hematology & Oncology
|
September 16, 2024
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia
David Sedloev, Qian Chen, Julia M Unglaub, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 4, 2026
Depletion of CD8<sup>+</sup> CAR T-cells leads to superior anti-tumor efficacy of pure CD4<sup>+</sup> CAR T-cells against Acute Leukemias
Qian Chen, David Sedloev, Hao Yao, et al.
Blood Advances
|
September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.
Cancer Discovery
|
March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Cell Stem Cell
|
May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Leukemia
|
July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Der Unfallchirurg
|
July 12, 2018
[Corrective osteotomy of the hand]
Frank Unglaub, Martin F Langer, Julia M Unglaub, et al.
International Orthopaedics
|
September 1, 2020
Long-term functional outcome after dorsal capsular imbrication for post-traumatic dorsal instability of the distal radioulnar joint
Julia M Unglaub, Thomas Heyse, Thomas Bruckner, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
|
July 29, 2021
Long-term results of more than 13 years after arthroscopic repair of triangular fibrocartilage complex (TFCC) Palmer 1B tears: a comparison with short- and mid-term results
Julia M Unglaub, Thomas Bruckner, Thomas J Heyse, et al.
Journal of Hematology & Oncology
|
September 16, 2024
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia
David Sedloev, Qian Chen, Julia M Unglaub, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 4, 2026
Depletion of CD8<sup>+</sup> CAR T-cells leads to superior anti-tumor efficacy of pure CD4<sup>+</sup> CAR T-cells against Acute Leukemias
Qian Chen, David Sedloev, Hao Yao, et al.
Blood Advances
|
September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.
Cancer Discovery
|
March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Cell Stem Cell
|
May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML
Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Leukemia
|
July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Page
of 1